How Sites Are Often Evaluated By Sponsors
Source: Clinical Leader
Adam Kinsey described how sponsor-site partnerships at Merck typically start small. Sites are evaluated not only on enrollment but on predictability and communication throughout a study. Reliable, transparent sites are more likely to be awarded future trials. This approach encourages organic, trust-based partnerships that evolve from successful collaboration.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
This website uses cookies to ensure you get the best experience on our website. Learn more